 |
|
 |
Sudafed Blocked Nose Spray 15ml |
|
SUDAFED® Blocked Nose Nasal Spray helps clear the stuffy, blocked up feeling in your nose and sinuses caused by colds and allergies such as hay fever. Locally applied, this non-drowsy spray gives effective congestion relief for up to 10 hours. Its active ingredient, xylometazoline, eases nose and sinus congestion fast.
|
|
This product is indicated for the symptomatic relief of nasal congestion associated with the common cold, influenza, sinusitis, allergic and non-allergic rhinitis, and other upper respiratory tract allergies.
|
|
Adults and children 12 years and over:
Nasal. One spray to be expressed into each nostril 2-3 times daily, as necessary.
Maximum daily dose: 3 sprays.
Use for more than seven consecutive days is not recommended, [See Undesirable effects].
Children under 12 years:
This product is not recommended for children under 12 years of age.
The Elderly
Experience has indicated that normal adult dosage is appropriate, [See Pharmacokinetics in the elderly].
Hepatic/renal dysfunction
Normal adult dosage is appropriate, [See Pharmacokinetic properties].
|
|
This product is contraindicated in individuals with known hypersensitivity to the product or any of its constituents.
This product is contraindicated in individuals who are taking or have taken, monoamine oxidase inhibitors within the preceding two weeks.
This product is contraindicated in individuals with hypophysectomy or surgery exposing dura mater.
There is minimal systemic absorption with topically applied imidazoline sympathomimetics such as xylometazoline, however, this product should be used with caution in patients suffering coronary artery disease, hypertension, hyperthyroidism or diabetes mellitus.
Due to the low systemic absorption of xylometazoline when administered intra-nasally, interaction with drugs administered via other routes is considered unlikely.
Xylometazoline nasal preparations are generally well tolerated following short-term use and local side effects are mild and infrequent. Localised burning, stinging, itching, soreness, dryness or irritation and sneezing may occur occasionally. Rarely, nausea and headache may occur.
Rebound congestion has been reported occasionally, particularly following longer-term use of xylometazoline.
|
|
Absorption, Distribution, Metabolism and Elimination
Little information is available concerning the absorption, distribution, metabolism and elimination of xylometazoline in man. Absorption into the nasal mucosal tissues is rapid.
Pharmacokinetics in Renal/Hepatic Impairment
There have been no specific studies of this product or xylometazoline in hepatic or renal impairment.
Pharmacokinetics in the Elderly
There have been no specific clinical studies of this product or xylometazoline in the elderly.
List of excipients
Benzalkonium chloride solution
Disodium edetate
Sodium dihydrogen phosphate dihydrate
Sodium monohydrogen phosphate dihydrate
Sodium chloride
Sorbitol solution, 70% (Non crystalline)
Purified water
|
|
 |